These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19909814)

  • 1. Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate.
    Huynh TT; Padois K; Sonvico F; Rossi A; Zani F; Pirot F; Doury J; Falson F
    Eur J Pharm Biopharm; 2010 Feb; 74(2):255-64. PubMed ID: 19909814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive thin films for the simultaneous delivery of microbicide and anti-inflammatory drugs in the treatment of periodontal diseases.
    Lim SY; Dafydd M; Ong J; Ord-McDermott LA; Board-Davies E; Sands K; Williams D; Sloan AJ; Heard CM
    Int J Pharm; 2020 Jan; 573():118860. PubMed ID: 31759104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of antimicrobial and antiviral drugs from methacrylate copolymer system: effect of copolymer molecular weight and drug loading on drug release.
    Tallury P; Airrabeelli R; Li J; Paquette D; Kalachandra S
    Dent Mater; 2008 Feb; 24(2):274-80. PubMed ID: 17628658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of liquid crystalline structure on chlorhexidine diacetate release.
    Farkas E; Zelkó R; Németh Z; Pálinkás J; Marton S; Rácz I
    Int J Pharm; 2000 Jan; 193(2):239-45. PubMed ID: 10606788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity and local release characteristics of chlorhexidine diacetate loaded within the dental copolymer matrix, ethylene vinyl acetate.
    Arnold RR; Wei HH; Simmons E; Tallury P; Barrow DA; Kalachandra S
    J Biomed Mater Res B Appl Biomater; 2008 Aug; 86(2):506-13. PubMed ID: 18335433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on controlled-release cellulose acetate films for local delivery of chlorhexidine, indomethacin, and meloxicam.
    Cetin EO; Buduneli N; Atlihan E; Kirilmaz L
    J Clin Periodontol; 2004 Dec; 31(12):1117-21. PubMed ID: 15560815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorhexidine salt-loaded polyurethane orthodontic chains: in vitro release and antibacterial activity studies.
    Padois K; Bertholle V; Pirot F; Hyunh TT; Rossi A; Colombo P; Falson F; Sonvico F
    AAPS PharmSciTech; 2012 Dec; 13(4):1446-50. PubMed ID: 23090109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
    Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
    Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate.
    Lboutounne H; Chaulet JF; Ploton C; Falson F; Pirot F
    J Control Release; 2002 Aug; 82(2-3):319-34. PubMed ID: 12175746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release.
    Lin DM; Kalachandra S; Valiyaparambil J; Offenbacher S
    Dent Mater; 2003 Nov; 19(7):589-96. PubMed ID: 12901982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres.
    Giunchedi P; Juliano C; Gavini E; Cossu M; Sorrenti M
    Eur J Pharm Biopharm; 2002 Mar; 53(2):233-9. PubMed ID: 11880008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration dependent aggregation properties of chlorhexidine salts.
    Zeng P; Zhang G; Rao A; Bowles W; Wiedmann TS
    Int J Pharm; 2009 Feb; 367(1-2):73-8. PubMed ID: 18926892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
    Claeys B; Vervaeck A; Hillewaere XK; Possemiers S; Hansen L; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Feb; 90():44-52. PubMed ID: 25448075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new degradable controlled release device for treatment of periodontal disease: in vitro release study.
    Steinberg D; Friedman M; Soskolne A; Sela MN
    J Periodontol; 1990 Jul; 61(7):393-8. PubMed ID: 2388137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anti-infective coatings of surgical sutures based on a combination of antiseptics and fatty acids.
    Matl FD; Zlotnyk J; Obermeier A; Friess W; Vogt S; Büchner H; Schnabelrauch H; Stemberger A; Kühn KD
    J Biomater Sci Polym Ed; 2009; 20(10):1439-49. PubMed ID: 19622281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorhexidine release from an experimental glass ionomer cement.
    Palmer G; Jones FH; Billington RW; Pearson GJ
    Biomaterials; 2004 Oct; 25(23):5423-31. PubMed ID: 15130727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for controlled delivery and sustained release of chlorhexidine in the oral environment.
    Garner S; Barbour ME
    Oral Dis; 2015 Jul; 21(5):641-4. PubMed ID: 25703954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of chlorhexidine from UDMA-TEGDMA resin.
    Anusavice KJ; Zhang NZ; Shen C
    J Dent Res; 2006 Oct; 85(10):950-4. PubMed ID: 16998139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiinfectious biomaterials. Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections.
    Schierholz JM; Rump A; Pulverer G
    Arzneimittelforschung; 1997 Jan; 47(1):70-4. PubMed ID: 9037447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.